GLP-1 Receptor Agonists and Cardiovascular Outcomes in 2026
A comprehensive review of GLP-1 receptor agonists and their cardiovascular benefits beyond weight management, including MACE reduction, heart failure outcomes, and implications for clinical practice in 2026.